A Seattle doctor reveals that despite changes in the CDC's advisory committee, COVID vaccine access will remain mostly unchanged. Confusion abounds as trust in health institutions wanes.
Oregon has taken significant steps to streamline COVID-19 vaccinations by allowing local pharmacies to administer shots without prescriptions. This change aims to ensure easier access for residents ahead of the winter virus season.
In a bold move, Senator Adam Schiff has urged health insurers to ensure full coverage of routine vaccines like COVID-19 and measles, regardless of controversial CDC recommendations. This comes after significant changes in the advisory panel led by vaccine skeptic Robert F. Kennedy Jr.
Amid concerns over vaccine access, America's Health Insurance Plans vows to cover all vaccines recommended by ACIP until 2026, despite potential changes by new committee members.
The U.S. is facing unprecedented health care cost increases, with employers likely to pass on hefty paycheck deductions and out-of-pocket expenses to workers. A new survey reveals a perfect storm brewing for American health care.
This autumn, parents face a confusing new landscape regarding childhood vaccinations amidst controversial changes to US vaccine guidance. Discover what you need to know about Covid-19 shots and more!
The FDA has approved new Covid vaccines, but confusion surrounds eligibility and coverage. Find out who can get vaccinated and how the new vaccines target the latest strains.
Many older Americans on Medicare are shocked to find that the newly approved Covid shots aren't covered, leading to hefty out-of-pocket expenses. Health officials claim coverage should be available, but patients report otherwise. What's going on?
Health Secretary RFK Jr. faces backlash over his claims about COVID-19 vaccine accessibility during a heated Senate hearing. Discover the truth behind the updated FDA guidelines and the barriers to vaccine access.
UnitedHealth Group's upcoming earnings report has sparked intense social media buzz as its stock faces a dramatic decline. Analysts weigh in on the potential for recovery or a value trap amid industry challenges.
